These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30911946)

  • 21. Impact of incidental findings on integrated 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in patients with gastric cancer.
    Tae CH; Lee JH; Choi JY; Min BH; Rhee PL; Kim JJ
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):34-40. PubMed ID: 25560093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and Economic Impact of Incidental Findings on
    Adams SJ; Rakheja R; Bryce R; Babyn PS
    Can Assoc Radiol J; 2018 Feb; 69(1):63-70. PubMed ID: 29458956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidental findings on 18-FDG PET-CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET-CT in patients with head and neck cancer.
    Casselden E; Sheerin F; Winter SC
    Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):243-247. PubMed ID: 30535976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
    Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
    Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers.
    Cohen VML; Pavlidou E; DaCosta J; Arora AK; Szyszko T; Sagoo MS; Szlosarek P
    Middle East Afr J Ophthalmol; 2018; 25(2):91-95. PubMed ID: 30122854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance.
    Bleicher J; Swords DS; Mali ME; McGuire L; Pahlkotter MK; Asare EA; Bowles TL; Hyngstrom JR
    J Surg Oncol; 2020 Dec; 122(8):1770-1777. PubMed ID: 33098702
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Lawal I; Lengana T; Ololade K; Boshomane T; Reyneke F; Modiselle M; Vorster M; Sathekge M
    Nuklearmedizin; 2017 Jun; 56(3):83-89. PubMed ID: 28154879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
    Mena E; Taghipour M; Sheikhbahaei S; Mirpour S; Xiao J; Subramaniam RM
    Clin Nucl Med; 2016 Sep; 41(9):e403-9. PubMed ID: 27355846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
    Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
    Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness of PET/CT Surveillance Schedules to Detect Distant Recurrence of Resected Stage III Melanoma.
    Dieng M; Turner RM; Lord SJ; Einstein AJ; Menzies AM; Saw RPM; Nieweg OE; Thompson JF; Morton RL
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
    Gellén E; Sántha O; Janka E; Juhász I; Péter Z; Erdei I; Lukács R; Fedinecz N; Galuska L; Remenyik É; Emri G
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1938-44. PubMed ID: 25753249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of FDG-PET/CT for Detection of Incidental Pre-Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings.
    Kunawudhi A; Wong AK; Alkasab TK; Mahmood U
    Asian Pac J Cancer Prev; 2016; 17(8):4143-7. PubMed ID: 27644675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidental radiologic findings at breast cancer diagnosis and likelihood of disease recurrence.
    Brothers JM; Kidwell KM; Brown RK; Henry NL
    Breast Cancer Res Treat; 2016 Jan; 155(2):395-403. PubMed ID: 26797222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
    Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
    J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidental Findings on FDG PET/CT in Head and Neck Cancer.
    Britt CJ; Maas AM; Kennedy TA; Hartig GK
    Otolaryngol Head Neck Surg; 2018 Mar; 158(3):484-488. PubMed ID: 29160180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Impact of whole body magnetic resonance imaging (MRI) in the management of melanoma patients, in comparison with positron emission tomography/computed tomography (TEP/CT) and CT].
    Dellestable P; Granel-Brocard F; Rat AC; Olivier P; Régent D; Schmutz JL
    Ann Dermatol Venereol; 2011 May; 138(5):377-83. PubMed ID: 21570561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.
    Belhocine T; Pierard G; De Labrassinne M; Lahaye T; Rigo P
    Oncologist; 2002; 7(4):271-8. PubMed ID: 12185291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
    Salem SS; Shahin MA
    Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.